Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry

Lip, Gregory ORCID: 0000-0002-7566-1626 (2021) Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry. European Journal of Clinical Investigation, 51 (3). e13385-.

Access the full-text of this item by clicking on the Open Access link.

Text
eci.13385.pdf - Published version
Download (376kB) | Preview

Official URL: https://onlinelibrary.wiley.com/doi/full/10.1111/e...

Abstract

Introduction Atrial fibrillation (AF) and diabetes mellitus (DM) constitute a heavy burden on healthcare expenditure due to their negative impact on clinical outcomes in the Middle East. The Atrial fibrillation Better Care (ABC) pathway provides a simple strategy of integrated approach of AF management: A—Avoid stroke; B—Better symptom control; C—Cardiovascular comorbidity risk management. Aims Evaluation of the AF treatment compliance to ABC pathway in DM patients in the Middle East. Assessment of the impact of ABC pathway adherence on all‐cause mortality and the composite outcome of stroke/systemic embolism, all‐cause death and cardiovascular hospitalisations. Methods From 2043 patients in the Gulf SAFE registry, 603 patients (mean age 63; 48% male) with DM were included in an analysis of ABC pathway compliance: A—appropriate use of anticoagulation according to CHA2DS2‐VASc score; B—AF symptoms management according to the European Heart Rhythm Association (EHRA) scale; C—Optimised cardiovascular comorbidities management. Results 86 (14.3%) patients were treated in compliance with the ABC pathway. During 1‐year follow‐up, 207 composite outcome events and 87 deaths occurred. Mortality was significantly lower in the ABC group vs non‐ABC (5.8% vs 15.9%, P = .0014, respectively). On multivariate analysis, ABC compliance was associated with a lower risk of all‐cause death and the composite outcome after 6 months (OR 0.18; 95% CI: 0.42‐0.75 and OR 0.54; 95% Cl: 0.30‐1.00, respectively) and at 1 year (OR 0.30; 95% Cl: 0.11‐0.76 and OR 0.57; 95% Cl: 0.33‐0.97, respectively) vs the non‐ABC group. Conclusions Compliance with the ABC pathway care was independently associated with the reduced risk of all‐cause death and the composite outcome in DM patients with AF, highlighting the importance of an integrated approach to AF management.

Item Type:	Article
Uncontrolled Keywords:	ABC pathway, all-cause death, anticoagulation, atrial fibrillation, stoke
Depositing User:	Symplectic Admin
Date Deposited:	22 Sep 2020 09:33
Last Modified:	18 Jan 2023 23:32
DOI:	10.1111/eci.13385
Open Access URL:	https://doi.org/10.1111/eci.13385
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3102160